Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Entourage Health Corp. Enters into Arrangement Agreement for Going-Private Transaction
TORONTO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (the “Company” or “Entourage”) is pleased to announce that it has entered into a definitive arrangement agreement (the “Arrangement Agreement”) with 1001007762 Ontario Inc. (the “Purchaser”) and 2437653 Ontario Inc. (the “Guarantor”) pursuant to which the Purchaser will acquire all of the issued and outstanding common shares of the Company (the “Common Shares”) pursuant to a statutory plan of arrangement under the Business Corporations Act (Ontario) (the “Transaction”). Certain obligations of the Purchaser under the Arrangement Agreement have been guaranteed by the Guarantor. Each of the Purchaser and the Guarantor are related parties of LiUNA Pension Fund of Central and Eastern Canada (“LPFCEC”).» Mehr auf globenewswire.com
Entourage Health Corp. (ETRGF) Q3 2024 Earnings Call Transcript
Entourage Health Corp. (OTCPK:ETRGF) Q3 2024 Earnings Conference Call November 29, 2024 10:00 AM ET Company Participants Catherine Flaman - Senior Director, Communications and Corporate Affairs George Scorsis - Chief Executive Officer and Executive Chairman Vaani Maharaj - Chief Financial Officer Operator Good morning, everyone, and welcome to the Entourage Health Corp Third Quarter 2024 Results Conference Call. At this time, all participants are in listen-only mode and the conference is being recorded.» Mehr auf seekingalpha.com
Entourage Health Reports Strong Third Quarter 2024 Financial Results
TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the three and nine months ended September 30, 2024. The Company will host a conference call to discuss its financial and business highlights on November 29, 2024, at 10 a.m. Eastern Time.» Mehr auf globenewswire.com
Unternehmenszahlen
(EUR) | Sep. 2024 | |
---|---|---|
Umsatz | 6,34 Mio | 4,18% |
Bruttoeinkommen | 1,91 Mio | 12,44% |
Nettoeinkommen | −5,56 Mio | 19,27% |
EBITDA | −744,99k | 68,53% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 1,03 Mio€ |
Anzahl Aktien | 308,39 Mio |
52 Wochen-Hoch/Tief | 0,0141€ - 0,00277€ |
Dividenden | Nein |
Beta | 1,51 |
KGV (PE Ratio) | −0,04 |
KGWV (PEG Ratio) | 0,00 |
KBV (PB Ratio) | −0,01 |
KUV (PS Ratio) | 0,04 |
Unternehmensprofil
Entourage Health Corp. beschäftigt sich mit der Produktion und dem Vertrieb von Cannabisprodukten für den medizinischen und den Erwachsenenmarkt in Kanada. Das Unternehmen bietet Cannabispflanzen, getrocknetes Cannabis, Öle, topische Produkte, Extrakte und Esswaren an. Es bietet seine Produkte unter den Markennamen Color Cannabis, Saturday Cannabis, Starseed Medicinals und Mary's Medicinals an. Das Unternehmen war früher als WeedMD Inc. bekannt und änderte im Juli 2021 seinen Namen in Entourage Health Corp. um. Der Hauptsitz von Entourage Health Corp. befindet sich in Toronto, Kanada.
Name | Entourage Health |
CEO | Vaani Maharaj |
Sitz | Toronto, on Kanada |
Website | |
Börsengang | |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
Pnk | ETRGF |
Tsxv | ENTG.V |
Frankfurt | 4WE0.F |
München | 4WE0.MU |
Assets entdecken
Shareholder von Entourage Health investieren auch in folgende Assets